Genetic susceptibility markers for a breast-colorectal cancer phenotype: Exploratory results from genome-wide association studies
Creators
-
Pande, Mala1
- Joon, Aron1
- Brewster, Abenaa M.1
- Chen, Wei V.1
-
Hopper, John L.2
- Eng, Cathy1
- Shete, Sanjay1
- Casey, Graham3
- Schumacher, Frederick4
- Lin, Yi5
- Harrison, Tabitha A.5
- White, Emily5
- Ahsan, Habibul6
- Andrulis, Irene L.7
- Whittemore, Alice S.8
-
John, Esther M.8
- Win, Aung Ko2
-
Makalic, Enes2
- Schmidt, Daniel F.2
- Kapuscinski, Miroslaw K.2
- Ochs-Balcom, Heather M.9
- Gallinger, Steven7
- Jenkins, Mark A.2
- Newcomb, Polly A.5
- Lindor, Noralane M.10
- Peters, Ulrike5
- Amos, Christopher I.11
- Lynch, Patrick M.1
- 1. University of Texas
- 2. University of Melbourne
- 3. University of Virginia
- 4. Case Western Reserve University
- 5. Fred Hutchinson Cancer Center
- 6. University of Chicago
- 7. University of Toronto
- 8. Stanford University
- 9. University at Buffalo
- 10. Mayo Clinic
- 11. Dartmouth College
Description
Background: Clustering of breast and colorectal cancer has been observed within some families and cannot be explained by chance or known high-risk mutations in major susceptibility genes. Potential shared genetic susceptibility between breast and colorectal cancer, not explained by high-penetrance genes, has been postulated. We hypothesized that yet undiscovered genetic variants predispose to a breast-colorectal cancer phenotype.
Methods: To identify variants associated with a breast-colorectal cancer phenotype, we analyzed genome-wide association study (GWAS) data from cases and controls that met the following criteria: cases (n = 985) were women with breast cancer who had one or more first- or second-degree relatives with colorectal cancer, men/women with colorectal cancer who had one or more first- or second-degree relatives with breast cancer, and women diagnosed with both breast and colorectal cancer. Controls (n = 1769), were unrelated, breast and colorectal cancer-free, and age- and sex- frequency-matched to cases. After imputation, 6,220,060 variants were analyzed using the discovery set and variants associated with the breast-colorectal cancer phenotype at P<5.0E-04 (n = 549, at 60 loci) were analyzed for replication (n = 293 cases and 2,103 controls).
Results: Multiple correlated SNPs in intron 1 of the ROBO1 gene were suggestively associated with the breast-colorectal cancer phenotype in the discovery and replication data (most significant; rs7430339, Pdiscovery = 1.2E-04; rs7429100, Preplication = 2.8E-03). In meta-analysis of the discovery and replication data, the most significant association remained at rs7429100 (P = 1.84E-06).
Conclusion: The results of this exploratory analysis did not find clear evidence for a susceptibility locus with a pleiotropic effect on hereditary breast and colorectal cancer risk, although the suggestive association of genetic variation in the region of ROBO1, a potential tumor suppressor gene, merits further investigation.
Data availability
Data are available from the Institutional Data Access / Ethics Committees for researchers who meet the criteria for access to confidential data, from the two consortia: Colon Cancer Family Registry (CCFR) and Breast Cancer Family Registry (BCFR). Accession codes are not reported because the GWAS data are not available through dbGAP but can be accessed by submitting a proposal and obtaining approval from the CCFR/BCFR (CCFR: http://www.coloncfr.org/collaboration; BCFR: http://www.bcfamilyregistry.org/for-researchers/initiate-collaborations). The CFRs have data and resource sharing plans in compliance with current NIH guidelines. This process is managed by the CCFR Program Manager (atemplet@fredhutch.org) and BCFR Review Coordinator (jenny.nguyen@cpic.org). Approved data requests are processed by the respective Informatics Center data management personnel. Contact information a. CCFR: http://www.coloncfr.org/about-us/program-manager b. BCFR: Jeanine Genkinger, PhD, MHS, Associate Professor, Department of Epidemiology, Mailman School of Public Health, Co-Director, Database Shared Resource, Herbert Irving Comprehensive Cancer Center (jg3081@cumc.columbia.edu), and Richard Buchsbaum, Data Manager (RB539@columbia.edu).
Files
journal.pone.0196245.pdf
Files
(2.0 MB)
| Name | Size | Download all |
|---|---|---|
|
Supporting information md5:638798c90d9a0593a43e6d9050ac61ae |
834.0 kB | Preview Download |
|
Article md5:103699686c9af2928719e2efa98e9df1 |
1.2 MB | Preview Download |
Additional details
Identifiers
- DOI
- 10.1371/journal.pone.0196245
- Other
- oai:uchicago.tind.io:6583
Funding
- National Cancer Institute
- UM1 CA164920
- National Cancer Institute
- UM1 CA167551
- National Cancer Institute
- U01/U24 CA074783
- National Cancer Institute
- U01/U24 CA074799
- National Cancer Institute
- U01 CA074778
- National Cancer Institute
- U01/U24 CA097735
- National Cancer Institute
- U01/U24 CA074794
- National Cancer Institute
- U01/U24 CA074800
- National Cancer Institute
- U01/U24 CA074806
- National Cancer Institute
- U01 CA137088
- National Cancer Institute
- K05 CA154337
- National Cancer Institute
- U01 CA188392
- National Cancer Institute
- K07 CA160753
- National Cancer Institute
- U01 CA122839
- National Cancer Institute
- R01 CA143237
- National Heart, Lung, and Blood Institute
- HHSN268201100046C
- National Heart, Lung, and Blood Institute
- HHSN268201100001C
- National Heart, Lung, and Blood Institute
- HHSN268201100002C
- National Heart, Lung, and Blood Institute
- HHSN268201100003C
- National Heart, Lung, and Blood Institute
- HHSN268201100004C
- National Heart, Lung, and Blood Institute
- HHSN271201100004C